Nektar Therapeutics
Trade Nektar Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NKTR
Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit.
NKTR Key Statistics
Stock Snapshot
With a market cap of 2.15B, Nektar Therapeutics(NKTR) trades at $63.65. The stock has a price-to-earnings ratio of -7.56.
During the trading session on 2026-06-28, Nektar Therapeutics(NKTR) shares reached a daily high of $64.34 and a low of $61.29. At a current price of $63.65, the stock is +3.9% higher than the low and still -1.1% under the high.
Trading activity shows a volume of 6.05M, compared to an average daily volume of 1.37M.
Over the past 52 weeks, Nektar Therapeutics(NKTR) stock has traded between a high of $109.00 and a low of $21.02.
Over the past 52 weeks, Nektar Therapeutics(NKTR) stock has traded between a high of $109.00 and a low of $21.02.
NKTR News
Howard W. Robin, President & CEO of Nektar Therapeutics (NKTR 3.75%), disclosed the sale of 20,000 shares in multiple open-market transactions on June 16 and Ju...
Analyst ratings
90%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.